Rohto Pharmaceutical Co.,Ltd. provided dividend guidance of JPY 12.00 per share for the second quarter of fiscal year ending March 31, 2024 as compared to paid dividend of JPY 20.00 per share same period a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,805 JPY | -2.65% | -11.74% | -1.34% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.34% | 4.21B | |
+38.13% | 705B | |
+32.82% | 583B | |
-3.67% | 364B | |
+20.13% | 332B | |
+4.93% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.68% | 169B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024